{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:39:00Z","timestamp":1792705140172,"version":"4.5.0"},"reference-count":88,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Child Neurol"],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:p>The neuronal ceroid lipofuscinoses constitute one of many groups of rare childhood diseases for which disease-modifying treatments are nonexistent. Disease-specific barriers to therapeutic success include incomplete understanding of disease pathophysiology and limitations of treatments that cannot adequately cross the blood-brain barrier to access the central nervous system. Therapeutic development in the neuronal ceroid lipofuscinoses shares many challenges with other rare diseases, such as incomplete understanding of natural history to inform trial design, need for alternatives to the randomized controlled clinical trial, requirement for more sensitive outcome measures to quantify disease, limited access to resources required to mount a clinical trial (including funding), and difficulties of recruiting a small sample to participation. Solutions to these barriers will require multicenter collaboration, partnership with patient organizations, training a new generation of researchers interested in rare diseases, and leveraging existing resources.<\/jats:p>","DOI":"10.1177\/0883073813495959","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T08:39:19Z","timestamp":1378456759000},"page":"1142-1150","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":219,"title":["Clinical Trials in Rare Disease"],"prefix":"10.1177","volume":"28","author":[{"given":"Erika F.","family":"Augustine","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Rochester Medical Center, Rochester, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather R.","family":"Adams","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Rochester Medical Center, Rochester, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Mink","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Rochester Medical Center, Rochester, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2013,9,6]]},"reference":[{"key":"bibr1-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2008.11.004"},{"key":"bibr2-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2008.12.008"},{"key":"bibr3-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21624"},{"key":"bibr4-0883073813495959","volume-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","author":"Mole S","year":"2011","edition":"2"},{"key":"bibr5-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2012.02680.x"},{"key":"bibr6-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1177\/0269216310391346"},{"key":"bibr7-0883073813495959","volume-title":"Eyr","author":"Stengel OC","year":"1826"},{"key":"bibr8-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9346-0"},{"key":"bibr9-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320310629"},{"key":"bibr10-0883073813495959","first-page":"369","volume":"57","author":"Lake BD","year":"1995","journal-title":"Preliminary studies on coculture experiments and on bone marrow transplant in late infantile Batten disease. Am J Med Genet"},{"key":"bibr11-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-973676"},{"key":"bibr12-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-973677"},{"key":"bibr13-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00782.x"},{"key":"bibr14-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.2000.tb04608.x"},{"key":"bibr15-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.8.1411"},{"key":"bibr16-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200x.2005.02126.x"},{"key":"bibr17-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22515"},{"key":"bibr18-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320310630"},{"key":"bibr19-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320310631"},{"key":"bibr20-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1994.tb11901.x"},{"key":"bibr21-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1053\/ejpn.2000.0455"},{"key":"bibr22-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1053\/ejpn.2000.0457"},{"key":"bibr23-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000307753.88839.29"},{"key":"bibr24-0883073813495959","first-page":"273","volume":"266","author":"Santavuori P","year":"1989","journal-title":"Adv Exp Med Biol"},{"key":"bibr25-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1091529"},{"key":"bibr26-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1985.tb03178.x"},{"key":"bibr27-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.9.1236"},{"key":"bibr28-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.1999.2815"},{"key":"bibr29-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/0303-8467(82)90062-2"},{"key":"bibr30-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9421-6"},{"key":"bibr31-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318237f649"},{"key":"bibr32-0883073813495959","unstructured":"Safety study of a gene transfer vector for children with late infantile neuronal ceroid lipofuscinosis. http:\/\/www.clinicaltrials.gov\/ct\/show\/NCT00151216.2005."},{"key":"bibr33-0883073813495959","unstructured":"Safety study of a gene transfer vector (Rh.10) for children with late infantile neuronal ceroid lipofuscinosis. http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01161576.2010."},{"key":"bibr34-0883073813495959","unstructured":"AAVRh.10 Administered to children with late infantile neuronal ceroid lipofuscinosis with uncommon genotypes or moderate\/severe impairment. http:\/\/clinicaltrials.gov\/show\/NCT01414985. 2010."},{"key":"bibr35-0883073813495959","unstructured":"Cellcept for treatment of juvenile neuronal ceroid lipofuscinosis. http:\/\/clinicaltrials.gov\/show\/NCT01399047. 2012."},{"key":"bibr36-0883073813495959","unstructured":"Cystagon to treat infantile neuronal ceroid lipofuscinosis. http:\/\/clinicaltrials.gov\/show\/NCT00028262. 2001."},{"key":"bibr37-0883073813495959","unstructured":"Safety and efficacy study of HuCNS-SC in subjects with neuronal ceroid lipofuscinosis. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01238315. 2010."},{"key":"bibr38-0883073813495959","unstructured":"Study of HuCNS-SC cells in patients with infantile or late infantile neuronal ceroid lipofuscinosis (NCL). http:\/\/clinicaltrials.gov\/show\/NCT00337636. 2006."},{"key":"bibr39-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2010.10.010"},{"key":"bibr40-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2007.09.012"},{"key":"bibr41-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2012.05.040"},{"key":"bibr42-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.9"},{"key":"bibr43-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23545"},{"key":"bibr44-0883073813495959","doi-asserted-by":"publisher","DOI":"10.2174\/138920111795542633"},{"key":"bibr45-0883073813495959","doi-asserted-by":"publisher","DOI":"10.55782\/ane-2008-1709"},{"key":"bibr46-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1053\/ejpn.2000.0436"},{"key":"bibr47-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1515\/BC.2008.009"},{"key":"bibr48-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2011.05.021"},{"key":"bibr49-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.143420"},{"key":"bibr50-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2008.02.049"},{"key":"bibr51-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000251268.41188.04"},{"key":"bibr52-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2743"},{"key":"bibr53-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.01.046"},{"key":"bibr54-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1097\/01.gim.0000232477.37660.fb"},{"key":"bibr55-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105233242104"},{"key":"bibr56-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91038-7"},{"key":"bibr57-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2007.02.008"},{"key":"bibr58-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e32834c20d9"},{"key":"bibr59-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-009-1164-2"},{"key":"bibr60-0883073813495959","volume-title":"Orphan Drug Act","author":"Congress US","year":"1983"},{"key":"bibr61-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2008.10.003"},{"key":"bibr62-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07816-9"},{"key":"bibr63-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320420420"},{"key":"bibr64-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320310607"},{"key":"bibr65-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1988.tb10770.x"},{"key":"bibr66-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821435bd"},{"key":"bibr67-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1038\/466160a"},{"key":"bibr68-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-11"},{"key":"bibr69-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21676"},{"key":"bibr70-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2010.11.164"},{"key":"bibr71-0883073813495959","unstructured":"FDA-NIH science of small clinical trials course. https:\/\/events-support.com\/events\/FDA-NIH_Science_Small_Clinical_Trials. Acce-ssed May 6, 2013."},{"key":"bibr72-0883073813495959","unstructured":"NIH-Network for Excellence in Neuroscience Clinical Trials. http:\/\/www.neuronext.org\/. Accessed May 6, 2013."},{"key":"bibr73-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2012.02.012"},{"key":"bibr74-0883073813495959","first-page":"302","volume":"33","author":"Hilbert JE","year":"2012","journal-title":"Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD). Contemp Clin Trials"},{"key":"bibr75-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000169019.41332.8a"},{"key":"bibr76-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000267885.47092.40"},{"key":"bibr77-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.10660"},{"key":"bibr78-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2012.03.003"},{"key":"bibr79-0883073813495959","unstructured":"Adams HR. Outcome Measures and Infrastructure for Phase III Studies in Batten Disease, JNCL-R13. National Institute of Neurological Disorders and Stroke."},{"key":"bibr80-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182377e29"},{"key":"bibr81-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.286"},{"key":"bibr82-0883073813495959","unstructured":"Food and Drug Administration Modernization Act. http:\/\/www.fda.gov\/RegulatoryInformation\/Legislation\/FederalFoodDrugandCosmeticActFDCAct\/SignificantAmendmentstotheFDCAct\/FDAMA\/FullTextofFDAMAlaw\/default.htm#SEC.%20112. Accessed May 6, 2013."},{"key":"bibr83-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-6296(02)00126-1"},{"key":"bibr84-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2010.12.002"},{"key":"bibr85-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3654"},{"key":"bibr86-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2012.02.005"},{"key":"bibr87-0883073813495959","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31826c19b4"},{"key":"bibr88-0883073813495959","unstructured":"NINDS Clinical Trial Methods Course. http:\/\/www.neurologytrials.org\/. Accessed May 6, 2013."}],"container-title":["Journal of Child Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0883073813495959","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0883073813495959","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0883073813495959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:33:40Z","timestamp":1777494820000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0883073813495959"}},"subtitle":["Challenges and Opportunities"],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":88,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1177\/0883073813495959"],"URL":"https:\/\/doi.org\/10.1177\/0883073813495959","relation":{},"ISSN":["0883-0738","1708-8283"],"issn-type":[{"value":"0883-0738","type":"print"},{"value":"1708-8283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}